Related Experiment Videos

Mutagenic/carcinogenic potential of DEHP and MEHP

Insights

Mono(2-ethylhexyl) phthalate (MEHP) demonstrated significant DNA damage and mutagenic effects in bacterial and mammalian cells. Di(2-ethylhexyl) phthalate (DEHP) also showed mutagenicity, with both compounds inducing mutations and chromosomal damage in hamster embryos.

Area of Science:

  • Toxicology
  • Genetics
  • Cell Biology

Background:

  • Di(2-ethylhexyl) phthalate (DEHP) is a widely used plasticizer with potential health concerns.
  • Understanding the mutagenic and carcinogenic activities of DEHP and its primary metabolite, mono(2-ethylhexyl) phthalate (MEHP), is crucial for risk assessment.

Purpose of the Study:

  • To investigate the mutagenic and carcinogenic potential of DEHP and MEHP.
  • To evaluate the DNA damaging effects of these compounds in various in vitro and in vivo models.

Main Methods:

  • Bacterial mutagenicity assays (Rec-assay, Ames test with Salmonella typhimurium TA-100).
  • Mammalian cell assays including gene mutation (8-azaguanine/6-thioguanine resistance), sister chromatid exchanges (SCE), chromosomal aberrations, and morphological transformation in Chinese hamster V79 cells.
  • Transplacental exposure study in Syrian golden hamsters, followed by embryonic cell analysis.

Main Results:

  • MEHP induced dose-dependent DNA damage in B. subtilis.
  • Both DEHP and MEHP exhibited mutagenicity in S. typhimurium TA-100.
  • MEHP caused gene mutations, SCE, and chromosomal aberrations in V79 cells.
  • Transplacental exposure to DEHP and MEHP resulted in mutations, chromosomal aberrations, and morphological transformation in embryonic cells.

Conclusions:

  • MEHP is a potent mutagen and genotoxic agent.
  • DEHP also possesses mutagenic properties.
  • Both compounds pose risks for developmental toxicity and carcinogenicity, warranting further investigation and regulatory consideration.

Related Concept Videos